Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Shanghai Journal of Preventive Medicine ; (12): 41-45, 2022.
Article in Chinese | WPRIM | ID: wpr-920536

ABSTRACT

Objective To explore the nutritional risk influencing factors in stroke patients, and to discuss the formulation of rehabilitation nursing countermeasures. Methods We randomly selected 152 patients with acute hemorrhagic stroke admitted to our hospital from July 2018 to July 2020. Based on the results of the mini nutritional assessment (MNA) score, the patients were divided into normal group (49 cases), risk group (53 cases), and bad group (50 cases). Single factor analysis and correlation analysis were used to analyze the nutritional risk factors, and the countermeasures for the influencing factors were discussed. Results Univariate analysis showed that stroke time, mechanical ventilation, swallowing dysfunction, ADL score, upper arm muscle circumference, serum albumin, and total lymphocyte count in risk and bad groups were different from the normal group. In comparison, the proportion of patients with mechanical ventilation and swallowing dysfunction was higher, and ADL score, upper arm muscle circumference, serum albumin level and total lymphocyte count were lower (P<0.05). The Spearman rank correlation analysis showed that the factors with differences in the univariate analysis also showed correlation (P<0.05). Among them, the positive correlation factors included the duration of stroke, receiving mechanical ventilation, swallowing dysfunction, NIHSS score, negatively related factors included ADL score, serum levels of albumin, transferrin, and hemoglobin. Multivariate Logistic regression analysis showed that stroke time (OR=1.739, P<0.001) and swallowing dysfunction (OR=3.966, P=0.008) were independent risk factors for malnutrition. ADL score (OR=0.687, P<0.001), upper arm muscle circumference (OR=0.770, P=0.012), serum albumin level (OR=0.870, P=0.003) were independent protective factors for malnutrition. Conclusion The nutritional status in stroke patients is not optimistic. Most patients have swallowing disorders, motor dysfunction, and poor self-care ability. At the same time, the body protein content in patients has decreased significantly. The clinical work is needed to deal with the patients' swallowing function recovery together with the treatment of nerve damage.

2.
Journal of Southern Medical University ; (12): 723-726, 2014.
Article in Chinese | WPRIM | ID: wpr-249372

ABSTRACT

<p><b>OBJECTIVE</b>To compare the effects of 15% hypertonic saline and 20% mannitol in doses of similar osmotic burden for treatment of intracranial hypertension in patients with severe traumatic brain injury.</p><p><b>METHODS</b>We used an alternating treatment protocol to compare the effects of hypertonic saline with that of mannitol given for episodes of increased intracranial pressure (ICP) in patients with severe brain injury. Standard guidelines for the management of severe traumatic brain injury were followed. For episodes of increased ICP, 20% mannitol (2 ml/kg, infused for over 20 min) and 15% saline (0.42 ml/kg, administered as a bolus via a central venous catheter) of similar osmotic burden were given alternately, with the choice of agent for the initial hypertensive event determined on a randomized basis. Reduction of ICP and duration of the action were recorded after each event.</p><p><b>RESULTS</b>The data were collected from 33 patients with 237 hypertensive events. The mean decrease in ICP was 8.7 mm Hg at 28.7∓9.3 min after mannitol treatment as compared with 9.3 mm Hg at 23.6∓7.1 min after treatment with hypertonic saline (P>0.05). The mean duration of the effect was 270 min for mannitol and 318 min for hypertonic saline (P>0.05).</p><p><b>CONCLUSIONS</b>Treatment with 15% hypertonic saline and 20% mannitol in doses of similar osmotic burden produces similar effects in management of increased ICP in patients with severe traumatic brain injury in terms of the time of action onset, maximum ICP reduction, and duration of action.</p>


Subject(s)
Humans , Brain Injuries , Therapeutics , Intracranial Hypertension , Therapeutics , Mannitol , Therapeutic Uses , Saline Solution, Hypertonic , Therapeutic Uses
SELECTION OF CITATIONS
SEARCH DETAIL